<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03054662</url>
  </required_header>
  <id_info>
    <org_study_id>002/MSHP/CNER-kp</org_study_id>
    <nct_id>NCT03054662</nct_id>
  </id_info>
  <brief_title>Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.</brief_title>
  <official_title>Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>World Federation of Hemophilia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to make an inventory of the condition and care of patients with haemophilia
      and carriers for haemophilia in Ivory Coast and to promote the use non substitutive
      strategies that are not costly and available in Ivory Coast, to improve the management of
      haemophilia in this country. The purpose of this project is to evaluate the extent to which
      the active promotion of these various measures will improve the care of patients with
      haemophilia and carriers in Ivory Coast.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Establish a baseline of the condition of haemophilia in Ivory Coast (number of patients,
           demographics, reassessment of diagnosis, joint status...).(year 1)

        2. Develop tools to assess the intervention (eg transcultural validation of QoL
           questionnaires, develop booklets to record bleedings...). (year 1)

        3. Intervention phase that will focus on education of patients and their family, education
           of caregivers, training of the laboratory to the diagnosis of haemophilia and promotion
           of non substitutive strategies to improve haemophilia care in Ivory Coast (DDAVP,
           antifibrinolytics, physiotherapy, dental care,...).

        4. Follow-up phase during 2 years.

        5. Outcome analysis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>monocentric prospective study with longitudinal data collection of a single group</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improve haemophilia care in Ivory Coast</measure>
    <time_frame>2 years after intervention</time_frame>
    <description>Compare QoL questionnaires before and after the intervention phase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improve haemophilia diagnosis of haemophilia in Ivory Coast</measure>
    <time_frame>3 years</time_frame>
    <description>Compare the number of patients with haemophilia between the beginning and the end of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improve haemophilia care in Ivory Coast</measure>
    <time_frame>2 years after intervention</time_frame>
    <description>Compare the pain assessment before and after the intervention phase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improve knowledge about haemophilia in Ivory Coast</measure>
    <time_frame>2 years after intervention</time_frame>
    <description>Compare the knowledge queestionnaires about haemophilia before and after the intervention phase</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Haemophilia</condition>
  <condition>Developing Countries</condition>
  <arm_group>
    <arm_group_label>Patients with Haemophilia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Male patients with severe and moderate haemophilia A and B in Ivory Coast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carriers for Haemophilia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carriers for severe and moderate haemophilia A and B in Ivory Coast</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Education</intervention_name>
    <description>Education of patients and caregivers about haemophilia and carriers of haemophilia.</description>
    <arm_group_label>Patients with Haemophilia</arm_group_label>
    <arm_group_label>Carriers for Haemophilia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Improve biological diagnosis and follow-up of haemophilia</intervention_name>
    <description>train the laboratory to the diagnosis ans follow-up un haemophilia</description>
    <arm_group_label>Patients with Haemophilia</arm_group_label>
    <arm_group_label>Carriers for Haemophilia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implement haemostatic non substitutive care of haemophilia</intervention_name>
    <description>Implement the use of DDAVP and antifibrinolytics in patients with haemophilia and symptomatic carriers</description>
    <arm_group_label>Patients with Haemophilia</arm_group_label>
    <arm_group_label>Carriers for Haemophilia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Implement non haemostatic care of haemophilia</intervention_name>
    <description>Implement regular physiotherapy, develop dental care, promote the regular use of pain killers</description>
    <arm_group_label>Patients with Haemophilia</arm_group_label>
    <other_name>Physiotherapy, dental care, pain killers</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males with severe and moderate haemophilia A and B in Ivory Coast (any age).

          -  Females over 12 years who are carriers for severe and moderate haemophilia A and B in
             Ivory Coast.

          -  Exclusion Criteria: subjects not willing to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine M Lambert, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine M Lambert, MD</last_name>
    <phone>+32-2-764.17.08</phone>
    <email>catherine.lambert@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cedric R Hermans, MD, PhD</last_name>
    <phone>+32-2-764.17.85</phone>
    <email>cedric.hermans@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Yopougon</name>
      <address>
        <city>Abidjan</city>
        <country>Côte D'Ivoire</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahima Sanogo, MD</last_name>
      <phone>+225-07918225</phone>
      <email>ibesan@yahoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Meité N'Dogomo, MD</last_name>
      <phone>+225-07918225</phone>
      <email>n_meite@yahoo.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Côte D'Ivoire</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2017</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Haemophilia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

